DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Squalene is an investigational drug.
There have been 12 clinical trials for Squalene. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2005.
The most common disease conditions in clinical trials are Hypercholesterolemia, Dyslipidemias, and Hyperlipoproteinemia Type II. The leading clinical trial sponsors are Takeda, Immune Design, and IDRI Corporation.
Recent Clinical Trials for Squalene
|A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail||IQVIA Biotech||Phase 2|
|A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail||Blueberry Therapeutics||Phase 2|
|The Effects of GLA on Human Volunteers||IDRI Corporation||Phase 1|